PUBLISHER: TechNavio | PRODUCT CODE: 2125983
PUBLISHER: TechNavio | PRODUCT CODE: 2125983
Global Bone Biopsy Market 2026-2030
The global bone biopsy market is forecasted to grow by USD 102308.1 thousand during 2025-2030, accelerating at a CAGR of 8.3% during the forecast period. The report on the global bone biopsy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing burden of bone cancer and metastatic disease diagnosis, expansion of oncology and specialty care infrastructure, increasing preference for minimally invasive biopsies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 7.9% |
| CAGR | 8.3% |
| Incremental Value | $102308.1 thousand |
Technavio's global bone biopsy market is segmented as below:
By Type
- Needle biopsy
- Open biopsy
By End-User
- Hospitals and clinics
- ASCs
- Diagnostic and research laboratories
By Application
- Oncology
- Infectious diseases
- Metabolic bone disorders
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the shift toward image guided biopsy procedures as one of the prime reasons driving the global bone biopsy market growth during the next few years. Also, integration of digital pathology into diagnostic workflows and expansion of outpatient and ambulatory procedure settings will lead to sizable demand in the market.
The report on the global bone biopsy market covers the following areas:
- Global bone biopsy market sizing
- Global bone biopsy market forecast
- Global bone biopsy market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global bone biopsy market vendors that include Argon Medical Devices Inc., Becton Dickinson and Co., Cook Medical LLC, Hologic Inc., INRAD Inc., IZI Medical Products, Medline Inc., Medtronic Plc, Merit Medical Systems Inc., Mermaid Medical Group, Moller Medical GmbH, pfm medical gmbh, Ranfac Corp., Stryker Corp., Teleflex Inc., TSK Laboratory Europe BV, Uresil LLC, Zimmer Biomet Holdings Inc.. Also, the global bone biopsy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Bone Biopsy Market 2020 - 2024
- Historic Market Size - Data Table on Global Bone Biopsy Market 2020 - 2024 ($ thousand)
- 5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
- 5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ thousand)
- 5.4 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ thousand)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
6 Qualitative Analysis
- 6.1 Impact of AI on global bone biopsy market
- 6.2 Impact of geopolitical conflicts on global bone biopsy market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Type
- 8.1 Market segments
- 8.2 Comparison by Type
- 8.3 Needle biopsy - Market size and forecast 2025-2030
- 8.4 Open biopsy - Market size and forecast 2025-2030
- 8.5 Market opportunity by Type
- Market opportunity by Type ($ thousand)
9 Market Segmentation by End-user
- 9.1 Market segments
- 9.2 Comparison by End-user
- 9.3 Hospitals and clinics - Market size and forecast 2025-2030
- 9.4 ASCs - Market size and forecast 2025-2030
- 9.5 Diagnostic and research laboratories - Market size and forecast 2025-2030
- 9.6 Market opportunity by End-user
- Market opportunity by End-user ($ thousand)
10 Market Segmentation by Application
- 10.1 Market segments
- 10.2 Comparison by Application
- 10.3 Oncology - Market size and forecast 2025-2030
- 10.4 Infectious diseases - Market size and forecast 2025-2030
- 10.5 Metabolic bone disorders - Market size and forecast 2025-2030
- 10.6 Market opportunity by Application
- Market opportunity by Application ($ thousand)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 India - Market size and forecast 2025-2030
- 12.5.3 Japan - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Colombia - Market size and forecast 2025-2030
- 12.6.7 South Africa - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ thousand)
- Data Tables on Market opportunity by geography ($ thousand)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Growing burden of bone cancer and metastatic disease diagnosis
- Expansion of oncology and specialty care infrastructure
- Increasing preference for minimally invasive biopsies
- 13.2 Market challenges
- High procedure and infrastructure costs
- Shortage of specialized clinical expertise
- Regulatory and compliance complexity
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Shift toward image guided biopsy procedures
- Integration of digital pathology into diagnostic workflows
- Expansion of outpatient and ambulatory procedure settings
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Argon Medical Devices Inc.
- Argon Medical Devices Inc. - Overview
- Argon Medical Devices Inc. - Product / Service
- Argon Medical Devices Inc. - Key offerings
- SWOT
- 15.5 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
- 15.6 Cook Medical LLC
- Cook Medical LLC - Overview
- Cook Medical LLC - Product / Service
- Cook Medical LLC - Key offerings
- SWOT
- 15.7 Hologic Inc.
- Hologic Inc. - Overview
- Hologic Inc. - Product / Service
- Hologic Inc. - Key offerings
- SWOT
- 15.8 IZI Medical Products
- IZI Medical Products - Overview
- IZI Medical Products - Product / Service
- IZI Medical Products - Key offerings
- SWOT
- 15.9 Medline Inc.
- Medline Inc. - Overview
- Medline Inc. - Product / Service
- Medline Inc. - Key news
- Medline Inc. - Key offerings
- SWOT
- 15.10 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
- 15.11 Merit Medical Systems Inc.
- Merit Medical Systems Inc. - Overview
- Merit Medical Systems Inc. - Business segments
- Merit Medical Systems Inc. - Key offerings
- Merit Medical Systems Inc. - Segment focus
- SWOT
- 15.12 Mermaid Medical Group
- Mermaid Medical Group - Overview
- Mermaid Medical Group - Product / Service
- Mermaid Medical Group - Key offerings
- SWOT
- 15.13 pfm medical gmbh
- pfm medical gmbh - Overview
- pfm medical gmbh - Product / Service
- pfm medical gmbh - Key offerings
- SWOT
- 15.14 Ranfac Corp.
- Ranfac Corp. - Overview
- Ranfac Corp. - Product / Service
- Ranfac Corp. - Key offerings
- SWOT
- 15.15 Stryker Corp.
- Stryker Corp. - Overview
- Stryker Corp. - Business segments
- Stryker Corp. - Key offerings
- Stryker Corp. - Segment focus
- SWOT
- 15.16 Teleflex Inc.
- Teleflex Inc. - Overview
- Teleflex Inc. - Business segments
- Teleflex Inc. - Key news
- Teleflex Inc. - Key offerings
- Teleflex Inc. - Segment focus
- SWOT
- 15.17 TSK Laboratory Europe BV
- TSK Laboratory Europe BV - Overview
- TSK Laboratory Europe BV - Product / Service
- TSK Laboratory Europe BV - Key offerings
- SWOT
- 15.18 Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. - Overview
- Zimmer Biomet Holdings Inc. - Business segments
- Zimmer Biomet Holdings Inc. - Key news
- Zimmer Biomet Holdings Inc. - Key offerings
- Zimmer Biomet Holdings Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
